598 related articles for article (PubMed ID: 1690210)
1. Different pattern of expression of cellular oncogenes in human non-small-cell lung cancer cell lines.
Kiefer PE; Wegmann B; Bacher M; Erbil C; Heidtmann H; Havemann K
J Cancer Res Clin Oncol; 1990; 116(1):29-37. PubMed ID: 1690210
[TBL] [Abstract][Full Text] [Related]
2. Amplification and expression of protooncogenes in human small cell lung cancer cell lines.
Kiefer PE; Bepler G; Kubasch M; Havemann K
Cancer Res; 1987 Dec; 47(23):6236-42. PubMed ID: 2824028
[TBL] [Abstract][Full Text] [Related]
3. Gene amplification in human lung cancer. The myc family genes and other proto-oncogenes and growth factor genes.
Bergh JC
Am Rev Respir Dis; 1990 Dec; 142(6 Pt 2):S20-6. PubMed ID: 2174659
[TBL] [Abstract][Full Text] [Related]
4. Specific expression of cellular oncogenes c-myc and c-myb in T-cell lines established from three types of bovine lymphosarcomas.
Ishiguro N; Matsui T; Shinagawa M
Am J Vet Res; 1993 Dec; 54(12):2010-4. PubMed ID: 8116930
[TBL] [Abstract][Full Text] [Related]
5. Expression of p64c-myc and neuroendocrine properties define three subclasses of small cell lung cancer.
Bepler G; Bading H; Heimann B; Kiefer P; Havemann K; Moelling K
Oncogene; 1989 Jan; 4(1):45-50. PubMed ID: 2536917
[TBL] [Abstract][Full Text] [Related]
6. The molecular genetics of human lung cancer.
Slebos RJ; Rodenhuis S
Eur Respir J; 1989 May; 2(5):461-9. PubMed ID: 2547647
[TBL] [Abstract][Full Text] [Related]
7. Differential expression of the c-erbB-2 gene in human small cell and non-small cell lung cancer.
Schneider PM; Hung MC; Chiocca SM; Manning J; Zhao XY; Fang K; Roth JA
Cancer Res; 1989 Sep; 49(18):4968-71. PubMed ID: 2569928
[TBL] [Abstract][Full Text] [Related]
8. Human small-cell lung cancers show amplification and expression of the N-myc gene.
Nau MM; Brooks BJ; Carney DN; Gazdar AF; Battey JF; Sausville EA; Minna JD
Proc Natl Acad Sci U S A; 1986 Feb; 83(4):1092-6. PubMed ID: 2869482
[TBL] [Abstract][Full Text] [Related]
9. Expression of cellular oncogenes in primary cells from human acute leukemias.
Mavilio F; Sposi NM; Petrini M; Bottero L; Marinucci M; De Rossi G; Amadori S; Mandelli F; Peschle C
Proc Natl Acad Sci U S A; 1986 Jun; 83(12):4394-8. PubMed ID: 3520570
[TBL] [Abstract][Full Text] [Related]
10. Progressive relaxation of Go-arrest controls and altered responsiveness to insulin, EGF and thrombin in CCL39 lung fibroblasts over-expressing myc and ras oncogenes.
Pichon F; Seuwen K; Pouysségur J; Lagarde AE
Oncogene; 1988 Oct; 3(4):373-81. PubMed ID: 3078948
[TBL] [Abstract][Full Text] [Related]
11. Amplification of oncogenes in lung carcinoma grafted in nude mice.
Chauvin C; Jacrot M; Riondel J; Brambilla E; Foote AM; Brambilla C; Benabid AL
Anticancer Res; 1989; 9(2):449-52. PubMed ID: 2568771
[TBL] [Abstract][Full Text] [Related]
12. Amplification, rearrangement, and elevated expression of c-myc in the human prostatic carcinoma cell line LNCaP.
Nag A; Smith RG
Prostate; 1989; 15(2):115-22. PubMed ID: 2678039
[TBL] [Abstract][Full Text] [Related]
13. C-myc, N-myc, N-ras, and c-erb-B: lack of amplification or rearrangement in human medullary thyroid carcinoma and a derivative cell line.
Yang KP; Castillo SG; Nguyen CV; Hickey RC; Samaan NA
Anticancer Res; 1990; 10(1):189-92. PubMed ID: 2185686
[TBL] [Abstract][Full Text] [Related]
14. Transition from SCLC to NSCLC phenotype is accompanied by an increased TRE-binding activity and recruitment of specific AP-1 proteins.
Risse-Hackl G; Adamkiewicz J; Wimmel A; Schuermann M
Oncogene; 1998 Jun; 16(23):3057-68. PubMed ID: 9662339
[TBL] [Abstract][Full Text] [Related]
15. Genetic alterations of c-myc, c-erbB-2, and c-Ha-ras protooncogenes and clinical associations in human breast carcinomas.
Garcia I; Dietrich PY; Aapro M; Vauthier G; Vadas L; Engel E
Cancer Res; 1989 Dec; 49(23):6675-9. PubMed ID: 2573420
[TBL] [Abstract][Full Text] [Related]
16. Radiosensitivity of small-cell lung cancer xenografts compared with activity of c-myc, N-myc, L-myc, c-raf-1 and K-ras proto-oncogenes.
Rygaard K; Slebos RJ; Spang-Thomsen M
Int J Cancer; 1991 Sep; 49(2):279-84. PubMed ID: 1652570
[TBL] [Abstract][Full Text] [Related]
17. Evidence by in situ hybridization that c-erbB-2 proto-oncogene expression is a marker of malignancy and is expressed in lung adenocarcinomas.
Pääkkö P; Nuorva K; Kamel D; Soini Y
Am J Respir Cell Mol Biol; 1992 Sep; 7(3):325-34. PubMed ID: 1355655
[TBL] [Abstract][Full Text] [Related]
18. Amplification of protooncogenes in surgical specimens of human lung carcinomas.
Shiraishi M; Noguchi M; Shimosato Y; Sekiya T
Cancer Res; 1989 Dec; 49(23):6474-9. PubMed ID: 2573414
[TBL] [Abstract][Full Text] [Related]
19. Comparison of cellular protooncogene activation and transformation-related activity of human melanocytes and metastatic melanoma.
Husain Z; FitzGerald GB; Wick MM
J Invest Dermatol; 1990 Nov; 95(5):571-5. PubMed ID: 2121834
[TBL] [Abstract][Full Text] [Related]
20. Human lung cancers growing on extracellular matrix: expression of oncogenes and growth factors.
Pavelic K; Antonic M; Pavelic L; Pavelic J; Pavelic Z; Spaventi S
Anticancer Res; 1992; 12(6B):2191-6. PubMed ID: 1363516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]